Clinical Trials Logo

Clinical Trial Summary

On the day of surgery, the first eye to be operated is randomised to receive a Vivinex , HOYA Surgical Optics GmbH or an Clareon, Alcon, Fort Worth, Texas. The second eye to be operated receives the other IOL type. A complete biomicroscopic examination, visual acuity testing using autorefractometer, contrast sensitivity testing, and standardised retroillumination photography for PCO evaluation, will be performed 6 month (30-60 days), 1.5 years (± 3 months) and 3 (± 3 months) years postoperatively.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04369482
Study type Interventional
Source Medical University of Vienna
Contact
Status Active, not recruiting
Phase N/A
Start date January 1, 2019
Completion date February 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06053554 - Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome N/A
Completed NCT03903965 - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed NCT04196673 - Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses N/A
Active, not recruiting NCT03390400 - Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence N/A
Recruiting NCT03525015 - Impact of a Printed Decision Aid on Cataract Surgery Choice N/A
Active, not recruiting NCT03465124 - Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery N/A
Not yet recruiting NCT04230629 - Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models N/A
Recruiting NCT04321226 - Femtosecond Laser-assisted Astigmatism Treatment Phase 4
Recruiting NCT03803852 - Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric N/A
Completed NCT06365762 - The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract Phase 1/Phase 2
Recruiting NCT05822089 - Intraindividual Comparison of EMO IOLs N/A
Completed NCT03390361 - Release of Proinflammatory Cytokines (IL-1β, IL-6) and Total-prostaglandin (PG) Following Femtosecond Laser-assisted Cataract Surgery Compared to Manual Cataract Surgery N/A